by Elizabeth A. Thomson, Materials Research Laboratory, Massachusetts Institute of Technology MIT and Boston University researchers and colleagues report a smart pill the size of a blueberry that could be a game changer in the diagnosis and treatment of bowel diseases. Here (L-R) Qijun Liu of Boston University, Maria Eugenia Inda of MIT, and Miguel Jimenez of MIT pose with...
by Kiel University Immune responses on intestinal mucosal barriers play a key role in chronic inflammatory bowel diseases. Depicted here is the interaction between T lymphocytes with human leukocyte antigen (HLA) complex and the antigen-presenting cell. Credit: Andre Franke/Renate Nikolaus, Kiel University Chronic inflammatory bowel diseases (IBDs) like Crohn’s disease and ulcerative colitis are characterized...
